• Increase font size
  • Default font size
  • Decrease font size

International Drug and Explosives Detection Firm IDenta Corp. CEO Reports on Future Direction of Company

Print E-mail
Monday, 27 July 2009 15:52

JERUSALEM--IDenta Corp. (PINKSHEETS: IDTA) CEO Yaacov Shoham today released a statement concerning the future direction of the company.

Shoham stated, "As a result of the recent hugely successful marketing trip to the United States, IDenta Corp has been presented with a variety of options that will help to determine the future direction of the company in the North American law enforcement agencies (federal, state and local levels). It is our intent to keep our shareholders and the general public informed as we embark on the future expansion of our company.

IDenta wants to share with the investors what the different possibilities are for the company in the most important market for our products -- the North American law enforcement market -- on the federal, state, local levels.

IDenta is on a different level of talks with venture capital companies, marketing firms and others that want to forge an alliance with IDenta to promote the growth of the company, and several possibilities have emerged.

1. A very strong possibility is a connection with an American company (based in New York and with a forensic products plant in South Carolina) that has the complete package of what IDenta is looking for in marketing, sales, connections, production, plants, workers, etc. and would be able to help us in meeting all aspects of establishing a strong foothold in the North American law enforcement markets due to the increased demand and marketing for our products.

With this alliance, all the infrastructure would be in place in a short time to meet production requirements in the North America region.

2. Another possibility would be to establish our own American marketing company in charge of USA, Mexico and Canadian law enforcement markets.

As a first step of this possibility, IDenta will have to hire marketing managers with a very strong reputation and background in the forensics markets. Due to the economical crisis in the USA, it is a good time to hire the best personnel.

3. An additional possibility includes increasing the existing marketing relationships of our current associates in the USA and establishing a relationship with a large marketing company (including in the forensics, based in Chicago) with which we have had meetings during the last few months.

4. IDenta has recently held several meetings in Israel and in the USA with a large American capital investment company, but IDenta has postponed the connections because the capital company has no added value in marketing and connections in the law enforcement markets.

IDenta is not rushing the decisions and doing the due diligence necessary to make the best decisions for the company and the shareholders."

The members of the IDenta team to decide the best decisions in the North America law enforcement markets are four persons, (the CEO, a university professor in Business Administration, IDenta's legal and business consulting and the chief scientist).

ABOUT IDENTA

Since 2003, IDenta Corporation has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for the both professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.

Information concerning IDenta's entire product line may be found at www.IDenta.biz





BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read in the About Us Section

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus
 
about 10 minutes ago $JNJ Zytiga, a Prostate Cancer Drug, Does Well in Trial http://t.co/v7YUm9b6
about 1 hour ago $PFE Pfizer Lung Drug Stops Deadly Child Cancers in Study | http://t.co/hcfdrnCY
about 2 hours ago Human Genome Looks to Anyone but GlaxoSmithKline | http://t.co/d4IMkIn3
about 3 hours ago When David Einhorn did not mention Herbalife $HLF as a potential short candidate, that stock shot up on Wednesday | http://t.co/XpFKihQS
about 4 hours ago Stock Market: Stocks Get Hammered On Disappointing Data, Greece Worries http://t.co/FyH8zpru
about 4 hours ago Synergy Pharmaceuticals (SGYP) May Be Ready To Roll - Small Cap Stock Market Investing Tips http://t.co/FHYXlF1Q
about 7 hours ago Alvine Presents Results from Phase 2A Trial of ALV003 in Celiac Disease Patients -2012 Digestive Diseases Week Meeting http://t.co/e6Rjhbj9
about 7 hours ago Newly discovered protein makes sure brain development isn't 'botched' http://t.co/ZcUMTZSg

navigation

Free Phone Trade Alerts

Benzinga.com supporter Seeking Alpha Certified